Authors: Armstrong, Gregory T., Arnold, Michael A., Blaes, Anne, Conces, Miriam R., Hasan, Hasibul, Henderson, Tara O., Im, Cindy, Lu, Zhanni, McDonald, Aaron J., Monick, Sarah, Moskowitz, Chaya S., Nanda, Rita, Neglia, Joseph P., Nolan, Vikki, Oeffinger, Kevin C., Rader, Ryan K., Robison, Leslie L., Sheade, Jori, Spector, Logan G., Stene, Emily, Turcotte, Lucie M., Wolfe, Heather, Yasui, Yutaka
Published: March 1, 2025
In a multicenter retrospective cohort study of 431 female childhood cancer survivors who developed subsequent breast cancer, survivors faced a 3.5-fold greater mortality risk (95% CI = 2.17-5.57) compared with matched females with first primary breast cancer (N = 344 matched pairs). Survivors were more frequently treated with mastectomy (81% vs 60%) and less likely to receive radiotherapy (18% vs 61%) or anthracyclines (47% vs 66%), reflecting therapeutic tradeoffs due to prior treatment exposures. Despite guideline-concordant treatment rates being similar (94% vs 93%), the excess mortality persisted, underscoring the importance of early detection through self-monitoring in this high-risk group.
